about
St John's Wort (Hypericum perforatum L.) photomedicine: hypericin-photodynamic therapy induces metastatic melanoma cell deathNaturally occurring food toxinsNeuroprotective Activity of Hypericum perforatum and Its Major ComponentsDifferential diagnosis of gallstones by using hypericin as a fluorescent optical imaging agentPygopus2 inhibits the efficacy of paclitaxel-induced apoptosis and induces multidrug resistance in human glioma cells.Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report.Necrosis targeted combinational theragnostic approach using radioiodinated Sennidin A in rodent tumor models.An overview of translational (radio)pharmaceutical research related to certain oncological and non-oncological applications.Development and applications of photo-triggered theranostic agentsDe novo sequencing of Hypericum perforatum transcriptome to identify potential genes involved in the biosynthesis of active metabolitesCommonly Used Dietary Supplements on Coagulation Function during SurgeryIn vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells.Downregulation of β1 -adrenergic receptors in rat C6 glioblastoma cells by hyperforin and hyperoside from St John's wort.Identification of kinase inhibitors that target transcription initiation by RNA polymerase IIPhotoactivation of hypericin decreases the viability of RINm5F insulinoma cells through reduction in JNK/ERK phosphorylation and elevation of caspase-9/caspase-3 cleavage and Bax-to-Bcl-2 ratio.Hypericin-bearing magnetic iron oxide nanoparticles for selective drug delivery in photodynamic therapy.Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase.Occurrence and Distribution of Phytochemicals in the Leaves of 17 In vitro Cultured Hypericum spp. Adapted to Outdoor Conditions.Photodynamic-therapy Activates Immune Response by disrupting Immunity Homeostasis of Tumor Cells, which Generates Vaccine for Cancer TherapyNatural biomolecules and protein aggregation: emerging strategies against amyloidogenesisCytotoxic and apoptogenic effect of hypericin, the bioactive component of Hypericum perforatum on the MCF-7 human breast cancer cell line.Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer Applications.Development of rapid and highly sensitive HSPA1A promoter-driven luciferase reporter system for assessing oxidative stress associated with low-dose photodynamic therapy.Hypericin-mediated photooxidative damage of α-crystallin in human lens epithelial cells.Biliary and duodenal drainage for reducing the radiotoxic risk of antineoplastic 131I-hypericin in rat modelsImproved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy.A single-dose toxicity study on non-radioactive iodinated hypericin for a targeted anticancer therapy in mice.Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments.Hypericins: biotechnological production from cell and organ cultures.Evaluation of the cytotoxic activity of Hypericum spp. on human glioblastoma A1235 and breast cancer MDA MB-231 cells.YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy.Biodistribution and anti-tumor efficacy of intratumorally injected necrosis-avid theranostic agent radioiodinated hypericin in rodent tumor models.Applicability of new degradable hypericin-polymer-conjugates as photosensitizers: principal mode of action demonstrated by in vitro models.Photosensitizing effects of hypericin on head neck squamous cell carcinoma in vitro.Enhancement of the photocytotoxic efficiency of sub-12 nm therapeutic polymeric micelles with increased co-localisation in mitochondria.Hypericin-PDT-induced rapid necrotic death in human squamous cell carcinoma cultures after multiple treatment.Growth inhibition of malignant glioblastoma by DING protein.Photodynamic mechanisms induced by a combination of hypericin and a chlorin based-photosensitizer in head and neck squamous cell carcinoma cells.Secondary metabolites of seven Hypericum species growing in Turkey.Chemical composition and antioxidant activities of the essential oil of Hypericum gaitii Haines - an endemic species of Eastern India.
P2860
Q21131978-276AE568-1806-48B4-BA2A-E4C9D8D5D802Q24620433-E8C622AA-09AE-400B-8FAC-7FEF828BC280Q26741405-5E5E3E54-7A33-41A3-940D-32B5E15336FBQ28828131-9163E24D-F50F-4B21-A0B0-D8582680995BQ33709499-1BFC0A87-5F32-4E1E-96E8-4D5BAB3FE37FQ33710092-895F6A0F-8898-432B-B6CE-A03B14BF3790Q33917524-007EE7D5-F2CA-4E1A-AF04-69FD12421CCBQ34093032-2F328C77-F4BC-4886-9AA6-F8BB54CA163FQ34349286-25E99FA1-AC45-4FB4-B05B-319A3E755C08Q34364487-DE0D0514-39A6-42E5-849D-B69D1BF9306FQ34517159-681BB0A0-92DB-4D15-91BC-F39053AFA150Q34517469-CECA5A1D-1AB8-4272-8E6B-402C5A642C69Q34707570-45DE958F-5F44-40FE-8F38-0D1B81E504CDQ35640132-9820843C-1E40-4045-AACE-8D48E0AE370BQ35652360-EEE60374-8FDA-4AD7-90DF-5AD4E8A7E529Q35863911-4CC21F6F-2F3F-417D-8FC3-F13F929AF77FQ36088575-7C5614EE-B9A9-4B3F-B437-422EBD3D2863Q36189431-EF3DC216-2199-4E6B-9E73-1E69419966FEQ36372462-85C551BA-D091-44E8-BFC9-8AEA90AB7253Q36538570-39B779E3-0C88-4F7E-A8FA-97F1970076F9Q36566111-3734F153-1D4C-48C4-99A8-9A15B88E16C0Q36609881-ADAD8767-D536-4D30-B00F-49D7961C2BB6Q36636438-61ACB206-9460-42AA-9DB3-BC29E10A245AQ36844106-5ACF4E77-F640-4D40-8BE1-E4C358718845Q37071343-66DFB53D-4419-4CEB-9E1D-9AA0D35C5BF3Q37588304-CA3DFA4C-F8D4-460A-95CE-479D40DC1A50Q37727160-AD9D0549-F79B-4D25-A939-1E1CA46A9421Q38119845-6682249E-B810-4729-BCF6-87304E0C4D9EQ38258706-FDFC1AC3-D78D-4ED6-A5DA-3B74A40B209FQ38755770-1E0B1624-1F2E-4E14-9C9F-54EBC9251F85Q38767465-2F1F1637-BD62-4227-B6C2-3E8A9A6B5A08Q38921976-40CBD469-1995-4515-8452-CA1F8774281EQ38953134-75D5A019-DB7E-4313-9573-01F43D7AC976Q39009629-71E78E3C-AFDD-4488-804D-D4DA4DF0EB35Q39092142-5B47799F-E08F-4414-915A-AAAC85DC9A15Q39272964-C4FC088A-F8CE-497A-953C-188637CD3184Q39448314-C3B6685C-83AC-4DE0-A53D-916C806EA50CQ39571260-9426E8A0-241F-4674-A75A-89916A2A3E0EQ39935682-B3424AB7-3976-43BC-8647-5778524DFD66Q46354038-68135E59-3081-4167-8001-27E680CD5DEB
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hypericins as potential leads for new therapeutics
@ast
Hypericins as potential leads for new therapeutics
@en
Hypericins as potential leads for new therapeutics.
@nl
type
label
Hypericins as potential leads for new therapeutics
@ast
Hypericins as potential leads for new therapeutics
@en
Hypericins as potential leads for new therapeutics.
@nl
prefLabel
Hypericins as potential leads for new therapeutics
@ast
Hypericins as potential leads for new therapeutics
@en
Hypericins as potential leads for new therapeutics.
@nl
P2860
P921
P356
P1476
Hypericins as potential leads for new therapeutics
@en
P2860
P304
P356
10.3390/IJMS11020562
P407
P577
2010-02-04T00:00:00Z